{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-006811","form_type":"8-K","ticker":"NDRA","cik":"0001681682","company_name":"ENDRA Life Sciences Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.320756+00:00","generated_at":"2026-05-19T13:25:52.918936+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"ENDRA posts updated investor presentation reflecting new business strategy announced March 31, 2025","bullets":["Filed under Item 7.01; presentation posted on company website without new financial or operational data.","No new material facts disclosed; presentation references previously announced strategy shift.","Filing contains only procedural language; investor gains no actionable information from this 8-K alone."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-006811","json":"https://secwatch.observer/filing/0001654954-25-006811.json","markdown":"https://secwatch.observer/filing/0001654954-25-006811.md","text":"https://secwatch.observer/filing/0001654954-25-006811.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681682/000165495425006811/0001654954-25-006811-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681682/000165495425006811/endra_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T13:25:52.918936+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}